$51.14
0.420.83%
Last update: Nov 5, 10:13 AM
Eton Pharmaceuticals Inc
ETONNASDAQ
The average analyst price target for Eton Pharmaceuticals is $56, 9.5% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $10 to $70. The latest change came on Aug 14, 2026, when Canaccord Genuity raised its price target on Eton Pharmaceuticals from $60 to $68 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
